Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 8417 - 8424 of 12011 results

What are the USPTO’s Patent Plans for Fiscal Year 2017?
March 14, 2016| Blog| Viewpoint

Attorney Bill Coffman Named in JD Supra's 2016 Reader’s Choice awards
March 14, 2016| Blog| Viewpoint

Report Calls for More Guidance on Medicaid Hospital Payments
March 14, 2016| News

Why Life Sciences Leases Are Not Your Average Transaction
March 14, 2016| News

Massachusetts SJC Lightens Plaintiffs’ Summary Judgment Burden in Employment Discrimination Cases
March 11, 2016| Blog| Viewpoint

Massachusetts Legislature Reaches Compromise on Opioid Legislation
March 11, 2016| Alert| Viewpoint

Amarin/FDA Settlement: A Significant First Amendment Victory for Off-Label Marketing
March 11, 2016| Blog| Viewpoint

BPCIA Patent Litigation Webinar Recap
March 11, 2016| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|

Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|
